In response to the FDA’s recent safety review of approved CAR-T therapies, Posei...
NeuroOne has now received another agency nod that expands upon the capabilities ...
In a move that marks a significant advancement in the treatment of sickle cell d...
At ISPOR 2023, where GlobalData had the opportunity to share some of our key ins...
The payment, which encompasses newly approved Casgevy, is the latest deal in a l...
The Covid-19 pandemic pushed the healthcare industry toward rapid digitalisation...
Abbisko Therapeutics has received fast track designation from the US FDA for pim...
Amgen has received US FDA priority review for its biologics licence application ...
Acadia received two patent rulings that strengthen Nuplazid’s patent position an...
Experts discussed the potential impacts of climate change on the pharma supply c...
Novo Nordisk will pay $92.5m in one-time cash payment to Alkermes, and the deal ...
A Phase II clinical trial treating 160 acute kidney injury patients with MTX652 ...
In this article, we’ll explore the patient communication risks that now confront...
When is a diagnostic test for a rare disease worth taking?
Sobering centers offer a safe place to recover from intoxication. Every communit...
For a 7-year-old girl, a gene therapy for beta thalassemia offered freedom. The ...
